Sign Up Today and Learn More About BioVentrix Stock
Invest in or calculate the value of your shares in BioVentrix or other pre-IPO companies through EquityZen's platform.
BioVentrix Stock (BION)
BioVentrix is a medical device company that improves and expands the treatment available for congestive heart failure.
About BioVentrix Stock
Founded
2003
Headquarters
San Ramon, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
BioVentrix Press Mentions
Stay in the know about the latest news on BioVentrix
BioVentrix, Inc. Announces German Reimbursement Designation
einpresswire • Mar 26, 2026
Financings for Feb. 18, 2026
bioworld • Feb 19, 2026
US IPO Weekly Recap: Clear Street postpones its IPO, as Japan-based payment firm PayPay submits filings
renaissancecapital • Feb 14, 2026
Cardiac medical device developer BioVentrix files for an $17 million IPO
renaissancecapital • Feb 13, 2026
First Patient Treated with BioVentrix® Revivent System in RELIVE Trial at Saint Luke’s Mid America Heart Institute
einpresswire • Nov 03, 2025
BioVentrix Management
Leadership team at BioVentrix
Co-founder and Director
Arthur Bertolero
VP of Medical Affairs & Co-Founder
Lon S. Annest
Join now and verify your accreditation status to gain access to:
- BioVentrix Current Valuation
- BioVentrix Stock Price
- BioVentrix Management
- Available deals in BioVentrix and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- BioVentrix Cap Table and Funding History by Share Class and Liquidity Preferences
- BioVentrix Revenue and Financials
- BioVentrix Highlights
- BioVentrix Business Model
- BioVentrix Risk Factors
- BioVentrix Research Report from SACRA Research
Trading BioVentrix Stock
How to invest in BioVentrix stock?
Accredited investors can buy pre-IPO stock in companies like BioVentrix through EquityZen funds. These investments are made available by existing BioVentrix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell BioVentrix stock?
Shareholders can sell their BioVentrix stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
